Head and neck mucosal melanoma: The United Kingdom national guidelines

August 25, 2020

Abstract

The United Kingdom head and neck mucosal melanoma guideline development group used an evidence-based systematic approach to make recommendations in key areas of uncertainty in the field, including accurate diagnosis and staging; the appropriate treatment pathway including surgery, adjuvant radiation and new systemic treatments, such as targeted agents and immunotherapy; and the surveillance of patients after treatment. The guidelines were sent for international peer review and have been accredited by the National Institute for Health and Care Excellence. A summary of key recommendations is presented. The full documents are available on the Melanoma Focus website.

Source:

Pablo Nenclares, Derfel Ap Dafydd, Izhar Bagwan, Donna Begg, Cyrus Kerawala, Emma King, Ken Lingley, Vinidh Paleri, Gillian Paterson, Miranda Payne, Priyamal Silva, Neil Steven, Nancy Turnbull, Kent Yip, Kevin J. Harrington, Head and neck mucosal melanoma: The United Kingdom national guidelines, European Journal of Cancer, Volume 138, 2020, Pages 11-18, ISSN 0959-8049, https://doi.org/10.1016/j.ejca.2020.07.017.

(http://www.sciencedirect.com/science/article/pii/S0959804920304123)